The F4/AS01(B) HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial

The impact of the investigational human immunodeficiency virus type 1 (HIV-1) F4/AS01(B) vaccine on HIV-1 viral load (VL) was evaluated in antiretroviral therapy (ART)-naive HIV-1 infected adults. This phase IIb, observer-blind study (NCT01218113), included ART-naive HIV-1 infected adults aged 18 to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Dinges, Warren, Girard, Pierre-Marie, Podzamczer, Daniel, Brockmeyer, Norbert H., García, Felipe., Harrer, Thomas, Lelievre, Jean-Daniel, Frank, Ian, Colin De Verdière, Nathalie, Yeni, Guy-Patrick, Ortega Gonzalez, Enrique, Rubio, Rafael, Clotet Sala, Bonaventura, DeJesus, Edwin, Pérez-Elias, Maria Jesus, Launay, Odile, Pialoux, Gilles, Slim, Jihad, Weiss, Laurence, Bouchaud, Olivier, Felizarta, Franco, Meurer, Anja, Raffi, François, Esser, Stefan, Katlama, Christine, Koletar, Susan L., Mounzer, Karam, Swindells, Susan, Baxter, John D., Schneider, Stefan, Chas, Julie, Molina, Jean-Michel, Koutsoukos, Marguerite, Collard, Alix, Bourguignon, Patricia, Roman, François
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
4850
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4753889/
https://ncbi.nlm.nih.gov/pubmed/26871794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados